Nancy davis, visionary philanthropist and founder of race to erase ms and cure addiction now appointed to the tharimmune board of directors

Red bank, nj / access newswire / august 5, 2025 / tharimmune, inc. (nasdaq:thar), ("tharimmune" or the "company), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and critical unmet medical needs, today proudly announced the appointment of nancy davis, a globally recognized philanthropist, tenacious advocate, and the visionary founder of the renowned race to erase ms and cure addiction now foundations, to its board of directors. ms. davis brings an unparalleled fusion of deep-seated patient advocacy, strategic fundraising, and a profound, personal commitment to accelerating scientific discovery in areas of critical unmet medical need.
THAR Ratings Summary
THAR Quant Ranking